"Welcome to St. Margaret’s Health, the premier provider of healthcare in the Illinois Valley since 1903. On January 1, 2021, St. Margaret’s Hospital and IVCH finalized arrangements to consolidate their healthcare operations to form a regional health network. Just as St. Margaret’s Hospital was renamed St. Margaret’s Health – Spring Valley, Illinois Valley Community Hospital is now renamed St. Margaret’s Health – Peru."

During the past decade, Illinois Valley Community Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 118 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 17 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois Valley Community Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 88 trials, followed by "National Cancer Institute (NCI)" with 64 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Valley Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 148 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Illinois Valley Community Hospital" are "Breast Cancer" (33 trials), "Lung Cancer" (19 trials), "Lymphoma" (18 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "Illinois Valley Community Hospital" in a lesser frequency.

Most popular intervention types in "Illinois Valley Community Hospital" are "Drug" (180 trials), "Other" (91 trials), "Biological" (83 trials), "Radiation" (35 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "placebo" (28 trials), "carboplatin" (18 trials), "Bevacizumab" (17 trials) and "bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Illinois Valley Community Hospital" are 167 trials for "All" genders, 39 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois Valley Community Hospital". undefined are not yet recruiting, 1 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 148 completed trials in Illinois Valley Community Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois Valley Community Hospital, 14 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".